Status: Recruiting
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
Participants needed: 177
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: C5 BiomedicalUpdated: Dec 27, 2024Locations: 1
Eligibility criteria
At least 18 years of age or older. [+10]
Target ulcer must be located on the plantar aspect of the foot and must be offlo... [+51]